Evidence map›Paper›PMID 42259813›Full record

ArticleNature communications2026

Mycobacterium tuberculosis IDH-PPARγ interaction suppresses GPX4 to drive macrophage ferroptosis and sustain persistent infection.

Wenyuan Pu, Ximeng Zhang, Man Tian, Zhiyi He, Jin Zhu, Shiyu Song, Li Li, Panpan Lian, Renwei Lu, Ranran Wang and 18 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Wenyuan Pu *Department of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, P. R. China.
Ximeng Zhang *Guangdong Provincial Key Laboratory of Infection Immunity & Inflammation, Department of Pathogen Biology, Shenzhen University Medical School, Shenzhen, P. R. China.
Man Tian *Department of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, P. R. China.
Zhiyi He *Department of Respiratory Medicine, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, P. R. China.
Jin ZhuHuadong Medical Institute of Biotechniques, Nanjing, P. R. China.
Shiyu SongNanjing Lupine (YuShanDou) Biomedical Research Institute Co. Ltd., Nanjing, P. R. China.
Li LiState Key Laboratory of Pharmaceutical Biotechnology, State Key Laboratory of Analytical Chemistry for Life Science, Department of Dermatology, Affiliated Nanjing Drum Tower Hospital, Medical School, Nanjing University, Nanjing, Jiangsu Province, P. R. China.
Panpan LianState Key Laboratory of Pharmaceutical Biotechnology, State Key Laboratory of Analytical Chemistry for Life Science, Department of Dermatology, Affiliated Nanjing Drum Tower Hospital, Medical School, Nanjing University, Nanjing, Jiangsu Province, P. R. China.
Renwei LuState Key Laboratory of Pharmaceutical Biotechnology, State Key Laboratory of Analytical Chemistry for Life Science, Department of Dermatology, Affiliated Nanjing Drum Tower Hospital, Medical School, Nanjing University, Nanjing, Jiangsu Province, P. R. China.
Ranran WangState Key Laboratory of Pharmaceutical Biotechnology, State Key Laboratory of Analytical Chemistry for Life Science, Department of Dermatology, Affiliated Nanjing Drum Tower Hospital, Medical School, Nanjing University, Nanjing, Jiangsu Province, P. R. China.ORCID http://orcid.org/0009-0004-1604-0178
Kai LinState Key Laboratory of Pharmaceutical Biotechnology, State Key Laboratory of Analytical Chemistry for Life Science, Department of Dermatology, Affiliated Nanjing Drum Tower Hospital, Medical School, Nanjing University, Nanjing, Jiangsu Province, P. R. China.
Chaode GuState Key Laboratory of Pharmaceutical Biotechnology, State Key Laboratory of Analytical Chemistry for Life Science, Department of Dermatology, Affiliated Nanjing Drum Tower Hospital, Medical School, Nanjing University, Nanjing, Jiangsu Province, P. R. China.
Junaid WazirState Key Laboratory of Pharmaceutical Biotechnology, State Key Laboratory of Analytical Chemistry for Life Science, Department of Dermatology, Affiliated Nanjing Drum Tower Hospital, Medical School, Nanjing University, Nanjing, Jiangsu Province, P. R. China.ORCID http://orcid.org/0000-0001-9299-4716
Caiyun WangDepartment of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, P. R. China.
Yixuan SunDepartment of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, P. R. China.
Jing YangGuangdong Provincial Key Laboratory of Infection Immunity & Inflammation, Department of Pathogen Biology, Shenzhen University Medical School, Shenzhen, P. R. China.
Yingwei ZhangState Key Laboratory of Pharmaceutical Biotechnology, State Key Laboratory of Analytical Chemistry for Life Science, Department of Dermatology, Affiliated Nanjing Drum Tower Hospital, Medical School, Nanjing University, Nanjing, Jiangsu Province, P. R. China.
Huimei ChenCentre for Computational Biology, Duke-NUS Medical School, Outram, Singapore.ORCID http://orcid.org/0000-0001-7788-1334
Enrico PetrettoCentre for Computational Biology, Duke-NUS Medical School, Outram, Singapore.ORCID http://orcid.org/0000-0003-2163-5921
Wangsen CaoState Key Laboratory of Pharmaceutical Biotechnology, State Key Laboratory of Analytical Chemistry for Life Science, Department of Dermatology, Affiliated Nanjing Drum Tower Hospital, Medical School, Nanjing University, Nanjing, Jiangsu Province, P. R. China.ORCID http://orcid.org/0000-0001-6209-3482
Rongrong FanDepartment of Medicine Huddinge, Unit for Gastroenterology and Nutrition, Karolinska Institutet, Huddinge, Sweden.ORCID http://orcid.org/0000-0002-5707-1497
Eckardt TreuterDepartment of Medicine Huddinge, Unit for Gastroenterology and Nutrition, Karolinska Institutet, Huddinge, Sweden.ORCID http://orcid.org/0000-0002-4147-8989
Xia ZhangNanjing Public Health Clinical Center, the second hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, P. R. China.
Nannan LiuResearch Center for High Altitude Medicine, Laboratory for High Altitude Medicine of Qinghai Province, Qinghai University, Xining, P. R. China.
Airong YangResearch Center for High Altitude Medicine, Laboratory for High Altitude Medicine of Qinghai Province, Qinghai University, Xining, P. R. China.
Xinchun ChenGuangdong Provincial Key Laboratory of Infection Immunity & Inflammation, Department of Pathogen Biology, Shenzhen University Medical School, Shenzhen, P. R. China. chenxinchun@szu.edu.cn.ORCID http://orcid.org/0000-0002-2101-9013
Hongwei WangState Key Laboratory of Pharmaceutical Biotechnology, State Key Laboratory of Analytical Chemistry for Life Science, Department of Dermatology, Affiliated Nanjing Drum Tower Hospital, Medical School, Nanjing University, Nanjing, Jiangsu Province, P. R. China. hwang@nju.edu.cn.ORCID http://orcid.org/0000-0003-2868-5112
Zhiqiang HuangState Key Laboratory of Pharmaceutical Biotechnology, State Key Laboratory of Analytical Chemistry for Life Science, Department of Dermatology, Affiliated Nanjing Drum Tower Hospital, Medical School, Nanjing University, Nanjing, Jiangsu Province, P. R. China. zhiqiang.huang@nju.edu.cn.ORCID http://orcid.org/0000-0001-5208-008X

Funding

Basic Research Program of Jiangsu Province BK20251988National Natural Science Foundation of China (National Science Foundation of China) 82571040
6 · The paper itself

Abstract

Mycobacterium tuberculosis (M.tb) actively reprograms host lipid metabolism during infection; however, the underlying mechanism remains poorly understood. How M.tb manipulates macrophage lipid metabolism to induce lipid peroxidation and ferroptosis for bacterial persistence remains a fundamental question. Here, using single-cell RNA sequencing and proteomics, we show that M.tb infection substantially upregulates peroxisome proliferator-activated receptor gamma (PPARγ) in macrophages. Mechanistically, M.tb isocitrate dehydrogenase (IDH) interacts with PPARγ and impairs its proteasomal degradation. Elevated PPARγ suppresses glutathione peroxidase 4 (Gpx4) expression by recruiting the NCOR/SMRT corepressor complex to the Gpx4 promoter, resulting in increased lipid peroxidation and ferroptosis in infected macrophages. In mice, PPARγ knockout or pharmacological inhibition decreases lung inflammation and M.tb burden, restores GPX4 expression, and enhances macrophage survival. Our findings reveal a mechanism by which M.tb exploits the IDH-PPARγ axis to induce ferroptosis and sustain persistent infection, identifying therapeutic targets for tuberculosis treatment through disruption of this interaction.

Indexed as

FerroptosisIsocitrate DehydrogenaseMacrophagesMycobacterium tuberculosisPhospholipid Hydroperoxide Glutathione PeroxidasePPAR gammaTuberculosisAnimalsHumansLipid MetabolismLipid PeroxidationMiceMice, Inbred C57BLMice, Knockoutglutathione peroxidase 4, mouseIsocitrate DehydrogenasePhospholipid Hydroperoxide Glutathione PeroxidasePPAR gammaPparg protein, mouse

Identifiers

PMID42259813
PMCPMC13402603

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.